视网膜
诱导多能干细胞
视网膜色素上皮
视网膜
斯塔加德特病
生物
黄斑变性
色素性视网膜炎
芯片上器官
胚胎干细胞
细胞生物学
神经科学
医学
眼科
遗传学
微流控
纳米技术
材料科学
基因
生物化学
作者
Kevin Achberger,Christopher Probst,Jasmin Haderspeck,Sylvia Bolz,Julia Rogal,Johanna Chuchuy,Marina Nikolova,Virginia Cora,Lena Antkowiak,Wadood Haq,Nian Shen,Katja Schenke‐Layland,Marius Ueffing,Stefan Liebau,Peter Loskill
出处
期刊:eLife
[eLife Sciences Publications Ltd]
日期:2019-08-27
卷期号:8
被引量:228
摘要
The devastating effects and incurable nature of hereditary and sporadic retinal diseases such as Stargardt disease, age-related macular degeneration or retinitis pigmentosa urgently require the development of new therapeutic strategies. Additionally, a high prevalence of retinal toxicities is becoming more and more an issue of novel targeted therapeutic agents. Ophthalmologic drug development, to date, largely relies on animal models, which often do not provide results that are translatable to human patients. Hence, the establishment of sophisticated human tissue-based in vitro models is of upmost importance. The discovery of self-forming retinal organoids (ROs) derived from human embryonic stem cells (hESCs) or human induced pluripotent stem cells (hiPSCs) is a promising approach to model the complex stratified retinal tissue. Yet, ROs lack vascularization and cannot recapitulate the important physiological interactions of matured photoreceptors and the retinal pigment epithelium (RPE). In this study, we present the retina-on-a-chip (RoC), a novel microphysiological model of the human retina integrating more than seven different essential retinal cell types derived from hiPSCs. It provides vasculature-like perfusion and enables, for the first time, the recapitulation of the interaction of mature photoreceptor segments with RPE in vitro. We show that this interaction enhances the formation of outer segment-like structures and the establishment of in vivo-like physiological processes such as outer segment phagocytosis and calcium dynamics. In addition, we demonstrate the applicability of the RoC for drug testing, by reproducing the retinopathic side-effects of the anti-malaria drug chloroquine and the antibiotic gentamicin. The developed hiPSC-based RoC has the potential to promote drug development and provide new insights into the underlying pathology of retinal diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI